Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PCS And Manufacturer Pharmacy Sales Reps Promote Switch Program

Executive Summary

PCS Health Systems is working with the two manufacturers in its program to promote Rx switches to "preferred" formulary drugs, PCS VP-Network Administration Douglas Stephens told the Center for Business Intelligence's Pricing, Reimbursement & Formulary Management conference July 30 in Atlantic City.

You may also be interested in...



Celebrex Switches Create Approximately 7% of Scripts For Merck Vioxx

Switches from Celebrex to Vioxx accounted for approximately 7% of prescriptions for Merck's COX-2 inhibitor during November.

Celebrex Switches Create Approximately 7% of Scripts For Merck Vioxx

Switches from Celebrex to Vioxx accounted for approximately 7% of prescriptions for Merck's COX-2 inhibitor during November.

Correction

During a recent formulary management conference, PCS VP-Network Administration Douglas Stephens referred to a switch program for Miles Adalat CC as an example of pharmacists being paid to switch to manufacturers' products. Mylan was not involved in the program discussed by Stephens (1"The Pink Sheet" Aug. 9, p. 11)

UsernamePublicRestriction

Register

PS034648

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel